Siegfried Holding AGXSWX:SFZN +0.07%93 5-Year Yield-on-Cost % is 0.55 as of Jul. 13, 2026, which is 12% above its 10-year median of 0.49. GuruFocus rates XSWX:SFZN with a GF Score™ of 93/100 and a GF Value™ of CHF92.32 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 516 Drug Manufacturers companies, Siegfried Holding AG ranks worse than 81.4% on this metric.
Siegfried Holding AG's yield on cost for the quarter that ended in Dec. 2025 was 0.55.
The historical rank and industry rank for Siegfried Holding AG's 5-Year Yield-on-Cost % or its related term are showing as below:
XSWX:SFZN'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.31 Med: 0.49 Max: 0.83
Current: 0.55
During the past 13 years, Siegfried Holding AG's highest Yield on Cost was 0.83. The lowest was 0.31. And the median was 0.49.
XSWX:SFZN's 5-Year Yield-on-Cost % is ranked worse than 81.4% of 516
companies
in the Drug Manufacturers industry
Industry Median: 2.245
vs XSWX:SFZN: 0.55
Siegfried Holding AG (XSWX:SFZN) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Siegfried Holding AG 5-Year Yield-on-Cost % Related Terms
XSWX:SFZN vs ZTS, UTHR, VTRS: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Siegfried Holding AG 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Siegfried Holding AG's 5-Year Yield-on-Cost % falls into.
Siegfried Holding AG 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Siegfried Holding AG (XSWX:SFZN) has a 5-Year Yield-on-Cost % of 0.55 as of Jul. 13, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Siegfried Holding AG and its competitors. This is 12% above median its historical median of 0.49. Over the past decade, Siegfried Holding AG's 5-Year Yield-on-Cost % has ranged from 0.31 to 0.83. According to the industry distribution chart, Siegfried Holding AG ranks #420 out of 516 companies in the Drug Manufacturers industry, placing it in the top 81.4%.
Is Siegfried Holding AG's 5-Year Yield-on-Cost % too high?
Siegfried Holding AG's current 5-Year Yield-on-Cost % of 0.55 is 12% above median its 10-year median of 0.49. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 0.83. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.25. Siegfried Holding AG's value of 0.55 is 75.5% below this industry median. Based on the distribution chart, Siegfried Holding AG ranks #420 out of 516 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Siegfried Holding AG has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Siegfried Holding AG's 5-Year Yield-on-Cost % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Siegfried Holding AG ranks #420 out of 516 companies for 5-Year Yield-on-Cost %. This places Siegfried Holding AG in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.25. Siegfried Holding AG's value of 0.55 is 75.5% below this benchmark. Historically, Siegfried Holding AG's own 5-Year Yield-on-Cost % has ranged from 0.31 to 0.83 over the past decade. While the company's 10-year median is 0.49 vs. the industry median of 2.25, Siegfried Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.25, based on 516 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Siegfried Holding AG's current 5-Year Yield-on-Cost % of 0.55 is 75.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Siegfried Holding AG and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Siegfried Holding AG's current 5-Year Yield-on-Cost % is 0.55, which is 12% above median its own 10-year median of 0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Siegfried Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Siegfried Holding AG (XSWX:SFZN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF92.32, compared to a current price of CHF72.50 — trading 21.5% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.55, which is 12% above median its 10-year median of 0.49 and 75.5% below the Drug Manufacturers industry median of 2.25. Siegfried Holding AG's overall GF Score™ is 93/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Siegfried Holding AG (XSWX:SFZN), the current 5-Year Yield-on-Cost % is 0.55 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Siegfried Holding AG (XSWX:SFZN) Overvalued in 2026?
Based on GuruFocus' analysis, Siegfried Holding AG stock appears to be undervalued.
The current stock price of CHF72.50 is trading 21.5% below its estimated GF Value™ of CHF92.32.
GuruFocus considers Siegfried Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:SFZN:
5-Year Yield-on-Cost %: 0.55 (12% above median its 10-year median of 0.49)
GF Value™: CHF92.32 vs. price of CHF72.50 (21.5% below fair value)
Industry Position: 75.5% below the Drug Manufacturers median (#420 of 516)
No single metric tells the full story. See the XSWX:SFZN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.
93GF Score
Get the complete analysis for XSWX:SFZN
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SFZN has been successfully added to your 